Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Wiley Interdisciplinary Reviews. RNA|July 30, 2013
Messenger RNA-based vaccines: progress, challenges, applicationsThomas Kramps, Jochen Probst
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 22, 2010
Delivery of messenger RNA using poly(ethylene imine)-poly(ethylene glycol)-copolymer blends for polyplex formation: biophysical characterization and in vitro transfection propertiesHeiko Debus, Patrick Baumhof, Jochen Probst, et al.
Genetic Vaccines and Therapy|May 31, 2006
Characterization of the ribonuclease activity on the skin surfaceJochen Probst, Sonja Brechtel, Birgit Scheel, et al.
European Journal of Immunology|October 3, 2006
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNABirgit Scheel, Steffen Aulwurm, Jochen Probst, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activityMariola Fotin-Mleczek, Katharina M Duchardt, Christina Lorenz, et al.
European Journal of Immunology|July 20, 2004
A conserved sequence in the mouse variable T cell receptor alpha recombination signal sequence 23-bp spacer can affect recombinationJochen Probst, Sibylle G Blumenthal, Stefan Tenzer, et al.
European Journal of Immunology|February 10, 2004
Immunostimulating capacities of stabilized RNA moleculesBirgit Scheel, Sybilla Braedel, Jochen Probst, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 13, 2005
Co-transfection of messenger RNA and siRNA as a method to study the efficiency of siRNAThorsten Mutzke, Gudrun Schubkegel, Regina Teufel, et al.
International Journal of Cancer|December 23, 2014
A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profileRegina Heidenreich, Edith Jasny, Aleksandra Kowalczyk, et al.
Genetic Vaccines and Therapy|August 24, 2005
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomasJean-Philippe Carralot, Benjamin Weide, Oliver Schoor, et al.
Pageof 2